Literature DB >> 35772522

Coffee and cigarettes: Modulation of high and low sensitivity α4β2 nicotinic acetylcholine receptors by n-MP, a biomarker of coffee consumption.

Roger L Papke1, Madison Karaffa2, Nicole A Horenstein3, Clare Stokes2.   

Abstract

Smokers report particular appreciation for coffee with their first cigarettes of the day. We investigated with voltage-clamp experiments, effects of aqueous extracts (coffees) of unroasted and roasted coffee beans on the activity of human brain nicotinic acetylcholine receptor (nAChR) subtypes expressed in Xenopus oocytes, looking at complex brews, low molecular weight (LMW) fractions, and specific compounds present in coffee. When co-applied with PNU-120596, a positive allosteric modulator (PAM), the coffees stimulated currents from cells expressing α7 nAChR that were larger than ACh controls. The PAM-dependent responses to green bean coffee were three-fold greater than those to dark roasted coffee, consistent with α7 receptor activation by choline, a component of coffee that is partially degraded in the roasting process. Coffees were tested on both high sensitivity (HS) and low sensitivity (LS) forms of α4β2 nAChR, which are associated with nicotine addiction. To varying degrees, these receptors were both activated and inhibited by the coffees and LMW extracts. We also examined the activity of nine small molecules present in coffee. Only two compounds, 1-methylpyridinium and 1-1-dimethylpiperidium, produced during the process of roasting coffee beans, showed significant effects on nAChR. The compounds were competitive antagonists of the HS α4β2 receptors, but were PAMs for LS α4β2 receptors. HS receptors in smokers are likely to progressively desensitize through a day of smoking but may be hypersensitive in the mornings when brain nicotine levels are low. A smoker's first cup of coffee may therefore balance the effects of the day's first cigarette in the brain.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Addiction; Coffee; Electrophysiology; Neuromodulation; Nicotine

Mesh:

Substances:

Year:  2022        PMID: 35772522      PMCID: PMC9524580          DOI: 10.1016/j.neuropharm.2022.109173

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.273


  51 in total

1.  An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype.

Authors:  R L Papke; M Bencherif; P Lippiello
Journal:  Neurosci Lett       Date:  1996-08-09       Impact factor: 3.046

2.  Daily Patterns of Caffeine Intake and the Association of Intake with Multiple Sociodemographic and Lifestyle Factors in US Adults Based on the NHANES 2007-2012 Surveys.

Authors:  Harris R Lieberman; Sanjiv Agarwal; Victor L Fulgoni
Journal:  J Acad Nutr Diet       Date:  2018-11-13       Impact factor: 4.910

Review 3.  Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction.

Authors:  Ruthie E Wittenberg; Shannon L Wolfman; Mariella De Biasi; John A Dani
Journal:  Neuropharmacology       Date:  2020-07-29       Impact factor: 5.250

Review 4.  Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects.

Authors:  A Nehlig; J L Daval; G Debry
Journal:  Brain Res Brain Res Rev       Date:  1992 May-Aug

5.  Similar activity of mecamylamine stereoisomers in vitro and in vivo.

Authors:  Roger L Papke; Clare Stokes; Pretal Muldoon; M Imad Damaj
Journal:  Eur J Pharmacol       Date:  2013-10-23       Impact factor: 4.432

6.  Human alpha4beta2 acetylcholine receptors formed from linked subunits.

Authors:  Yan Zhou; Mark E Nelson; Alexander Kuryatov; Catherine Choi; John Cooper; Jon Lindstrom
Journal:  J Neurosci       Date:  2003-10-08       Impact factor: 6.167

7.  Nicotinic acetylcholine receptor availability in cigarette smokers: effect of heavy caffeine or marijuana use.

Authors:  Arthur L Brody; Robert Hubert; Michael S Mamoun; Ryutaro Enoki; Lizette Y Garcia; Paul Abraham; Paulina Young; Mark A Mandelkern
Journal:  Psychopharmacology (Berl)       Date:  2016-07-01       Impact factor: 4.530

8.  Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors.

Authors:  Mark E Nelson; Alexander Kuryatov; Catherine H Choi; Yan Zhou; Jon Lindstrom
Journal:  Mol Pharmacol       Date:  2003-02       Impact factor: 4.436

Review 9.  New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs.

Authors:  Deniz Bagdas; Mine S Gurun; Pamela Flood; Roger L Papke; M Imad Damaj
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 10.  Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors.

Authors:  Roger L Papke; Nicole A Horenstein
Journal:  Pharmacol Rev       Date:  2021-07       Impact factor: 18.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.